Pan-Canadian Lung Cancer Observational Study (PALEOS)

Launched by WILLIAM OSLER HEALTH SYSTEM · Jan 8, 2021

Keywords

ClinConnect Summary

The Pan-Canadian Lung Cancer Observational Study (PALEOS) is a research project aimed at understanding lung cancer in Canada. This study will collect information about patients with specific types of lung cancer, including those with certain genetic changes like ALK, EGFR, and others. The researchers plan to start with these groups and hope to include patients with other rare types of lung cancer in the second year. The goal is to gather valuable data that can help improve future treatments and care for lung cancer patients.

To be eligible for this study, participants need to be adults aged 18 and older who have been diagnosed with lung cancer since 2006 and are receiving or planning to receive cancer care in Canada. Importantly, participants must be able to provide consent to join the study. Those who take part can expect to share their health information and experiences, which will contribute to a better understanding of lung cancer and potentially lead to advancements in treatment. This study is currently recruiting participants of all genders, and it aims to make a meaningful impact on lung cancer care in Canada.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Adults aged 18 years or older having a documented lung cancer diagnosis since 2000.
• Exclusion Criteria:
• • • Patients that decline to provide informed consent.